Articles
Inside 'The Pitt' Season 2: Deeper Character Journeys Amid Medical Drama
Noah Wyle Returns as Dr. Robby in a Season Focused on Trust, New Challenges, and Contemporary Healthcare Issues
The second season of the acclaimed medical drama 'The Pitt' resumes with Noah Wyle reprising his role as Dr. Michael Robinavitch (Robby), embarking on...
Abbott: Not Cheap, But Built To Compound Through Volatility
High-quality cash flow, steady dividends, and diversified device/nutrition mix — buy selectively with stops.
Abbott mixes durable end-markets (cardiovascular, diabetes, diagnostics, nutrition) with strong cash conversion and a conservative balance sheet. At ~...
Nikki Glaser Prepares for 2026 Golden Globes with Focus on Monologue Challenges
Host navigates delicate celebrity humor and evolving current events ahead of Sunday’s ceremony
Comedian Nikki Glaser, returning as host of the 2026 Golden Globes, faces distinct challenges crafting her opening monologue, notably with jokes about...
Hims & Hers: Upgrading to Buy as Subscriber Momentum and ARPU Drive a Clear Re-rating Path
Strong top-line acceleration, positive operating cash flow and a big investing push create an asymmetric risk/reward — actionable buy with defined entry, stop and targets.
Hims & Hers (HIMS) is showing renewed revenue momentum and healthy operating cash generation after a period of heavy reinvestment. Q3 2025 revenue jum...
November Sees Significant Decline in U.S. Job Vacancies Amid Steady Economic Growth
Persistent low recruitment contrasts with robust quarterly GDP increase
U.S. job openings experienced a notable decrease in November, dropping to 7.1 million from 7.4 million in October, indicating a cautious approach by e...
Monte Rosa Therapeutics Sees Shares Surge Following Promising Phase 1 Study Data
Interim results from MRT-8102 trials show significant anti-inflammatory effects and strong safety profile, boosting investor confidence.
Monte Rosa Therapeutics Inc. disclosed interim findings from its ongoing Phase 1 clinical trial examining MRT-8102 for inflammatory conditions associa...
Notable Midweek Stock Movers Include Monte Rosa Therapeutics and Ventyx Biosciences
Despite mixed U.S. stock market performance, several biopharmaceutical and technology stocks surged on positive corporate developments
U.S. equities showed a varied performance with the Dow Jones index declining moderately on Wednesday. However, select stocks in the biotechnology and ...
Stock Trading Taxation Essentials: A Practical Guide to Managing Taxes and Optimizing After-Tax Returns
For beginner and intermediate stock traders seeking to understand tax rules, plan trades efficiently, and improve after-tax outcomes
Taxes are an often overlooked yet vital aspect of successful stock trading that can significantly impact your net returns. This comprehensive guide br...
Albertsons Posts Mixed Q3 Results Amid Digital Growth and Margins Pressure
Company beats earnings estimates but sales miss expectations; updates full-year outlook with cautious guidance
Albertsons Companies reported its third-quarter fiscal 2025 results with adjusted earnings per share surpassing analyst estimates, driven by growth in...
Brian Armstrong Clarifies Views on Insider Participation in Prediction Markets
Coinbase CEO emphasizes nuanced approach to insider involvement depending on market purpose
Brian Armstrong, CEO of Coinbase Global Inc., addressed recent misinterpretations of his comments on the role of insiders in prediction markets. He di...
US Equities Experience Modest Gains as UniFirst Shares Decline Post-Q1 Update
Mixed Sector Performances Mark Wednesday’s Trading; Key Movers Include UniFirst, Innovative Eyewear, and Ventyx Biosciences
On Wednesday, US stock indices moved slightly higher with the Dow Jones Industrial Average edging up marginally, supported by gains in healthcare shar...
Teck Resources: A Copper Growth Play as AI and Electrification Lift Demand
Actionable long trade on TECK shares - prefer a measured entry ahead of merger and QB2-led production step-up
Teck has repositioned itself into a low-carbon metals company with copper now the primary EBITDA driver. With Quebrada Blanca 2 (QB2) ramping Teck's a...